SKU(재고 관리 코드):PAB889Mu01
Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2)
Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2)
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
Product No.
PAB889Mu01
Organism Species
Mus musculus (Mouse).
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPB889Mu01-Recombinant Cyclin Dependent Kinase 2 (CDK2)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
500µg/mL
Organism Species More
Homo sapiens (Human), Rattus norvegicus (Rat)
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against CDK2. It has been selected for its ability to recognize CDK2 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Magazine |
Citations |
Leukemia & Lymphoma |
The nanoparticulate Quillaja saponin KGI exerts anti-proliferative effects by down-regulation of cell cycle molecules in U937 and HL-60 human leukemia cells Pubmed: 24138332 |
Future Medicinal Chemistry |
Construction of some cytotoxic agents with aurone and furoaurone scaffolds pubmed:29235893 |
Synthesis of Novel Heterocyclic Compounds Containing Benzothiophene of Expected Anticancer Activity. : |
Catalog No. |
Related products for research use of Mus musculus (Mouse) Organism species |
Applications (RESEARCH USE ONLY!) |
RPB889Mu01 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
RPB889Mu03 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
RPB889Mu02 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
PAB889Mu01 |
WB; IHC; ICC; IP. |
|
PAB889Mu02 |
WB; IHC; ICC; IP. |
|
PAB889Mu03 |
WB; IHC; ICC; IP. |
|
LAB889Mu71 |
Biotin-Linked Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) |
WB; IHC; ICC. |